CST5 and systemic mastocytosis: Remarkably, S100A8 was found to be more concentrated in SM patients than in healthy controls in our previous investigation [13], and thus, its detection in the mPC associated with cystatin D-C26 in the SM group encourages us to carry out further investigations on the possible use of this protein as a candidate SM biomarker.